CASI Pharmeceuticals

Career Opportunities

VICE PRESIDENT, CORPORATE FINANCE & STRATEGY

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. We focus on building a pipeline through mutually beneficial business development transactions. Our strategy leverages our resources and expertise in China to develop and commercialize innovative products in China and other markets.

We are a NASDAQ-listed company. Although we are headquartered in Rockville, Maryland with R&D operations in Beijing, we will consider and welcome a remote-based position in California, Northeast Region, and other strategic locations with financial communities.

THE POSITION
We are currently seeking a Vice President, Corporate Finance & Strategy who will play a major role in executing the business strategy of the Company. The successful candidate will provide leadership in the areas of fund-raising, financial and corporate strategies, and make corporate presentations to the financial community and investors. This position will also be integral to the Company’s investment relations activities and help steer the flow of financial and other information among shareholders and the investing community, and will help to develop communications, strategies and to implement programs to keep the financial community current on company performance and industry trends.

The ideal candidate will be a hands-on, innovative, out-of-the box thinker, who takes pride in their “rollup my sleeves” attitude. The candidate understands what it takes to grow a company and work in a fast-paced entrepreneurial environment as a member of the senior management team. It is imperative that the potential candidate becomes familiar with CASI’s mission, products, corporate and financial strategies to facilitate presenting the company to the financial community. The candidate must possess exceptional presentation and interpersonal skills.

PROFESSIONAL QUALIFICATIONS
Successful candidates must have a Bachelor’s degree in business or a scientific discipline; a degree in a life science plus a M.B.A. would be ideal. A minimum of 15 years in the financial community, preferably in the biotechnology, life science or healthcare space. Candidate must have exceptional presentation, interpersonal, and organizational skills and be able to travel domestically on a regular basis as needed to proactively engage the financial community.

TO APPLY
CASI offers an excellent compensation and benefits package and is an equal opportunity employer. Please send resume, cover letter, and any supporting materials to CASI at: careers@casipharmaceuticals.com. All candidates must successfully pass a background and professional reference check.

MANAGER OF BUSINESS DEVELOPMENT

Search & Evaluation – External Innovation

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary commercial focus on China. We focus on building a pipeline through mutually beneficial business development transactions. Our strategy leverages our resources and expertise in China to develop and commercialize innovative products in China and other markets.

We are a NASDAQ-listed company. Although we are headquartered in Rockville, Maryland with R&D operations in Beijing, we welcome and will consider a remote-based position, particularly in the San Francisco area, Boston or other strategic locations. The position can be director level, depending on the candidate’s experience and skill set.

THE POSITION

We are currently seeking a Manager of Business Development, Search & Evaluation for External Innovation, who will work with and report to the VP of Business Development. The Manager will search and evaluate new opportunities that will support executing the business strategy of the Company with the goal of developing prospects with biotech and pharmaceutical companies looking to expand into the Chinese region and report these opportunities to the VP of Business Development. Specifically, we are looking for regional rights with regard to innovative, patented therapeutics currently in late-stage clinical trials that are not currently available or approved in China, or earlier-stage products in innovative areas.

The Manager will identify corporate alliances for drug candidates to be developed in China and work with the VP of Business Development to execute on these opportunities. The candidate would assist the VP of Business Development by attending meetings and industry conferences. It is imperative that the potential candidate becomes familiar with CASI’s products and strategies to facilitate presenting the programs to potential partners.

PROFESSIONAL QUALIFICATIONS

Successful candidates must have a Bachelor’s degree in business or a scientific discipline; a degree in a life science plus a M.B.A. would be ideal. A minimum of 5 years of transactional business development experience. The ideal candidate must have strong technical/scientific skills as well as experience in the biotech/pharma industry in order to assist the VP, of Business Development in attending partnering meetings, scientific/clinical conferences and search multiple sources for new BD leads. Excellent presentation, oral, and written communications skills are a must. Candidate must be able to prioritize and juggle multiple projects and opportunities at once.

TO APPLY

CASI offers an excellent compensation and benefits package and is an equal opportunity employer. Please send resume, cover letter, and any supporting materials to CASI’s human resources, attn.: careers@casipharmaceuticals.com. All candidates must successfully pass a criminal background check.

About Us

A leading US-headquartered, NASDAQ-listed, biopharmaceutical company targeting the global market, with a focus on China.

Learn More

In the News

CASI's turnaround turns eastward; firm seeks to be Celgene of China

Read Article →

Poster

Antitumor activity, safety and predictive biomarker results of ENMD-2076 administered to patients with recurrent ovarian clear cell carcinoma (OCCC): A trial of the Princess Margaret Phase II Consortium

Download →

Poster

Senescence as a Mechanism of Resistance to Aurora Kinase Inhibition with ENMD-2076 in p53 mutated Triple-Negative Breast Cancer (TNBC) Models

Download →